Press Release

Lung Cancer Therapeutics Market 2020 | Clinical Analysis, Latest Innovations, Impacting Factors, Growth opportunities, Drivers, Dynamics And Strategic Research, Challenges By 2026

Lung Cancer Therapeutics Market to Reach US$ 48,725.9 Mn, Driven by Increasing Cancer Awareness, says Fortune Business Insights

Targeted segment is forecast to emerge dominant among various therapies in the Lung Cancer Therapeutics market, finds Fortune Business Insights in a new study. The study is titled “Lung Cancer Therapeutics Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2026.” According to the study, the Lung Cancer Therapeutics market will exhibit an exponential CAGR of 13.0% to reach a value of US$ 48,725.9 Mn by 2026 from US$ 18,327.6 Mn in 2018.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/lung-cancer-therapeutics-market-100473

Lung cancer is considered one of the leading causes of death by cancer.Cancer can be a result of continuous exposure to asbestos, and unhealthy lifestyle that includes habits such as pipe smoking, cigarette smoking, cigar smoking. The rising incidence of lung cancer is subsequenetly fuelling demand for various therapies in the Lung Cancer Therapeutics market.Targeted therapy is expected to emerge dominant among other therapies such as vaccine therapy, radiation therapy, chemotheraoy, surgery, and immunotherapy. targeted therapy segment accounted for a share of 51.1% in the year 2018. This is because of the rise in focus towards the diagnosis of lung cancer and positive outcome of targeted therapy that is increasing its demand in the global market.

Introduction

  • Research Scope
  • Market Segmentation
  • Research Methodology
  • Definitions and Assumptions

However, the immunotherapy segment is anticipated to grow at the fastest CAGR during the forecast period. This is because of the rise in the number of product launches related to treating lung cancer. The availability of abundant resources is creating new opportunities of growth in the market during the coming years.

KEY COMPANIES COVERED IN THE REPORT

  • Genentech (F. Hoffmann-La Roche Ltd)
  • Eli Lilly and Company
  • Celgene Corporation
  • AstraZeneca
  • Pfizer Inc.
  • Sanofi
  • Novartis AG
  • Astellas
  • Bristol Myers Squibb
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Millennium Pharmaceuticals, Inc. (Takeda)
  • Merck Sharp & Dohme Corp.

Request Customization of this [email protected] https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/lung-cancer-therapeutics-market-100473

Related Reports:

Regenerative Medicine Market Size & Industry Share by Leading Companies, Opportunities, Revenue Growth, Trends and Outlook (2020-2026)

Service Robotics Market Size & Industry Share by Leading Companies, Opportunities, Revenue Growth, Trends and Outlook (2020-2026)

ePharmacy Market Size & Industry Share by Leading Companies, Opportunities, Revenue Growth, Trends and Outlook (2020-2026)

 

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close